Managing weight gain in patients with severe mental illness.
Patients with severe mental illnesses such as bipolar disorder and schizophrenia have significantly increased rates of early mortality compared with the general population. Increased mortality in the mentally ill is often due to medical comorbidities associated with overweight or obesity. Weight gain can be associated with the mental disorder itself or with the pharmacotherapy used to treat the mental disorder. Effective weight-neutral and weight-reducing medical agents are available, and the use of an appropriate pharmacotherapy regimen with behavior modification and patient education may help manage body weight in patients with serious mental illnesses.
McIntyre
Roger S
RS
Department of Psychiatry and Pharmacology, University of Toronto, and the Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada.
D019440:Anti-Obesity Agents / Q000627:therapeutic use; D001521:Behavior Therapy; D001714:Bipolar Disorder / Q000188:drug therapy / Q000453:epidemiology / Q000401:mortality; D001835:Body Weight / Q000187:drug effects; D015897:Comorbidity; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy / Q000453:epidemiology / Q000628:therapy*; D009765:Obesity / Q000188:drug therapy / Q000453:epidemiology; D010353:Patient Education as Topic; D012559:Schizophrenia / Q000188:drug therapy / Q000453:epidemiology / Q000401:mortality; D015430:Weight Gain / Q000187:drug effects
D019440:Anti-Obesity Agents